NOD

シグナル伝達経路

研究分野

阻害剤の選択性比較

カタログ番号 製品カタログ 溶解度(25°C)
DMSO アルコール
S2863 ML130 (Nodinitib-1) <1 mg/mL 57 mg/mL '2 mg/mL
S0004 NOD-IN-1 <1 mg/mL 69 mg/mL ''''6 mg/mL
S0349 Inarigivir soproxil 25 mg/mL 100 mg/mL '''''60 mg/mL

NOD製品

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S2863

ML130 (Nodinitib-1)

ML130 (Nodinitib-1) is a potent and selective inhibitor of NOD1 with IC50 of 0.56 μM, inhibits NF-κB activation, exhibits 36-fold selectivity over NOD2.

S0004

NOD-IN-1

NOD-IN-1 (MDK19922, Compound 4) is a potent mixed inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptor 1 (NOD1) and NOD2 with IC50 of 5.74 μM and 6.45 μM, respectively.

S0349

Inarigivir soproxil

Inarigivir soproxil (GS 9992, SB 9200) is an oral agonist of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways. Inarigivir soproxil has broad-spectrum antiviral activity against RNA viruses with EC50 of 2.2 μM and 1.0 μM for HCV 1a and HCV 1b.

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S2863

ML130 (Nodinitib-1)

ML130 (Nodinitib-1) is a potent and selective inhibitor of NOD1 with IC50 of 0.56 μM, inhibits NF-κB activation, exhibits 36-fold selectivity over NOD2.

S0004

NOD-IN-1

NOD-IN-1 (MDK19922, Compound 4) is a potent mixed inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptor 1 (NOD1) and NOD2 with IC50 of 5.74 μM and 6.45 μM, respectively.

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S0349

Inarigivir soproxil

Inarigivir soproxil (GS 9992, SB 9200) is an oral agonist of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways. Inarigivir soproxil has broad-spectrum antiviral activity against RNA viruses with EC50 of 2.2 μM and 1.0 μM for HCV 1a and HCV 1b.